# Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

> **NCT01110785** · PHASE2 · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 46 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** panitumumab
- **DRUG:** simvastatin
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01110785
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2012-04
- **Final completion:** —
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110785, "Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01110785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*